USD 46.12
(-2.91%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 19.1 Billion EUR | -12.09% |
2022 | 21.73 Billion EUR | -6.22% |
2021 | 23.17 Billion EUR | -2.16% |
2020 | 23.68 Billion EUR | 7.07% |
2019 | 22.12 Billion EUR | 65.83% |
2018 | 13.34 Billion EUR | 1.09% |
2017 | 13.19 Billion EUR | -8.69% |
2016 | 14.45 Billion EUR | 3.16% |
2015 | 14 Billion EUR | 10.48% |
2014 | 12.67 Billion EUR | 28.41% |
2013 | 9.87 Billion EUR | -0.46% |
2012 | 9.91 Billion EUR | 12.07% |
2011 | 8.85 Billion EUR | 23.0% |
2010 | 7.19 Billion EUR | 17.28% |
2009 | 6.13 Billion EUR | -4.64% |
2008 | 6.43 Billion EUR | 10.51% |
2007 | 5.82 Billion EUR | -5.12% |
2006 | 6.13 Billion EUR | 81.94% |
2005 | 3.37 Billion EUR | 6.12% |
2004 | 3.17 Billion EUR | -5.71% |
2003 | 3.37 Billion EUR | -10.45% |
2002 | 3.76 Billion EUR | -13.65% |
2001 | 4.35 Billion EUR | 24.88% |
2000 | 3.49 Billion EUR | -5.77% |
1999 | 3.7 Billion EUR | 31.58% |
1998 | 2.81 Billion EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 18.7 Billion EUR | -2.58% |
2024 Q1 | 19.2 Billion EUR | 0.53% |
2023 Q2 | 21.84 Billion USD | -0.57% |
2023 Q4 | 21.08 Billion EUR | -1.26% |
2023 FY | 19.1 Billion EUR | -12.09% |
2023 Q3 | 21.35 Billion USD | -2.26% |
2023 Q1 | 21.97 Billion USD | 1.11% |
2022 FY | 21.73 Billion EUR | -6.22% |
2022 Q4 | 21.73 Billion EUR | 2.32% |
2022 Q3 | 21.23 Billion EUR | 3.0% |
2022 Q2 | 20.61 Billion EUR | 2.15% |
2022 Q1 | 20.18 Billion EUR | -0.99% |
2021 FY | 23.17 Billion EUR | -2.16% |
2021 Q3 | 20.38 Billion EUR | 1.04% |
2021 Q2 | 20.17 Billion EUR | -13.99% |
2021 Q4 | 20.38 Billion EUR | 0.01% |
2021 Q1 | 23.45 Billion EUR | 21.18% |
2020 Q3 | 20.39 Billion EUR | -2.27% |
2020 Q2 | 20.86 Billion EUR | 0.31% |
2020 Q1 | 20.8 Billion EUR | 5.56% |
2020 FY | 23.68 Billion EUR | 7.07% |
2020 Q4 | 19.35 Billion EUR | -5.08% |
2019 Q4 | 19.7 Billion EUR | 0.42% |
2019 FY | 22.12 Billion EUR | 65.83% |
2019 Q3 | 19.62 Billion EUR | 2.46% |
2019 Q1 | 19.12 Billion EUR | 43.38% |
2019 Q2 | 19.15 Billion EUR | 0.15% |
2018 Q2 | 13.06 Billion EUR | -1.35% |
2018 FY | 13.34 Billion EUR | 1.09% |
2018 Q4 | 13.34 Billion EUR | 0.75% |
2018 Q3 | 13.24 Billion EUR | 1.34% |
2018 Q1 | 13.24 Billion EUR | 0.37% |
2017 Q2 | 14.02 Billion EUR | -3.17% |
2017 FY | 13.19 Billion EUR | -8.69% |
2017 Q4 | 13.19 Billion EUR | -2.8% |
2017 Q3 | 13.57 Billion EUR | -3.17% |
2017 Q1 | 14.48 Billion EUR | -1.59% |
2016 Q4 | 14.71 Billion EUR | 7.06% |
2016 Q1 | 13.46 Billion EUR | -2.11% |
2016 Q2 | 14.13 Billion EUR | 4.99% |
2016 Q3 | 13.74 Billion EUR | -2.76% |
2016 FY | 14.45 Billion EUR | 3.16% |
2015 Q2 | 13.57 Billion EUR | -1.77% |
2015 Q3 | 13.48 Billion EUR | -0.69% |
2015 Q4 | 13.75 Billion EUR | 2.01% |
2015 FY | 14 Billion EUR | 10.48% |
2015 Q1 | 13.82 Billion EUR | 9.01% |
2014 Q1 | 9.99 Billion EUR | 1.19% |
2014 Q2 | 10.62 Billion EUR | 6.33% |
2014 FY | 12.67 Billion EUR | 28.41% |
2014 Q3 | 11.42 Billion EUR | 7.57% |
2014 Q4 | 12.67 Billion EUR | 10.94% |
2013 Q3 | 9.95 Billion EUR | -1.99% |
2013 Q4 | 9.87 Billion EUR | -0.84% |
2013 Q2 | 10.16 Billion EUR | 1.68% |
2013 Q1 | 9.99 Billion EUR | 0.73% |
2013 FY | 9.87 Billion EUR | -0.46% |
2012 FY | 9.91 Billion EUR | 12.07% |
2012 Q1 | 9.63 Billion EUR | 8.84% |
2012 Q3 | 9.67 Billion EUR | -7.73% |
2012 Q2 | 10.48 Billion EUR | 8.83% |
2012 Q4 | 9.91 Billion EUR | 2.55% |
2011 Q1 | 6.77 Billion EUR | -5.8% |
2011 FY | 8.85 Billion EUR | 23.0% |
2011 Q4 | 8.85 Billion EUR | 15.48% |
2011 Q3 | 7.66 Billion EUR | -0.32% |
2011 Q2 | 7.68 Billion EUR | 13.43% |
2010 FY | 7.19 Billion EUR | 17.28% |
2010 Q1 | 6.51 Billion EUR | 6.17% |
2010 Q3 | 6.77 Billion EUR | -9.04% |
2010 Q2 | 7.44 Billion EUR | 14.25% |
2010 Q4 | 7.19 Billion EUR | 6.29% |
2009 FY | 6.13 Billion EUR | -4.64% |
2009 Q4 | 6.13 Billion EUR | 0.0% |
2009 Q1 | 6.5 Billion EUR | 1.06% |
2009 Q2 | 6.37 Billion EUR | -1.94% |
2008 Q1 | 5.47 Billion EUR | -5.89% |
2008 FY | 6.43 Billion EUR | 10.51% |
2008 Q3 | 6.19 Billion EUR | 8.96% |
2008 Q4 | 6.43 Billion EUR | 3.89% |
2008 Q2 | 5.68 Billion EUR | 3.74% |
2007 Q1 | 6.06 Billion EUR | -1.19% |
2007 FY | 5.82 Billion EUR | -5.12% |
2007 Q4 | 5.82 Billion EUR | -0.2% |
2007 Q3 | 5.83 Billion EUR | -5.42% |
2007 Q2 | 6.16 Billion EUR | 1.74% |
2006 Q1 | 7.15 Billion EUR | 112.26% |
2006 Q4 | 6.13 Billion EUR | -2.15% |
2006 Q3 | 6.27 Billion EUR | -0.88% |
2006 FY | 6.13 Billion EUR | 81.94% |
2006 Q2 | 6.32 Billion EUR | -11.62% |
2005 FY | 3.37 Billion EUR | 6.12% |
2005 Q4 | 3.37 Billion EUR | -1.62% |
2005 Q3 | 3.42 Billion EUR | 0.26% |
2005 Q1 | 3.2 Billion EUR | 0.97% |
2005 Q2 | 3.41 Billion EUR | 6.56% |
2004 FY | 3.17 Billion EUR | -5.71% |
2004 Q4 | 3.17 Billion EUR | -7.39% |
2004 Q3 | 3.43 Billion EUR | -3.73% |
2004 Q2 | 3.56 Billion EUR | 0.04% |
2004 Q1 | 3.56 Billion EUR | 5.71% |
2003 FY | 3.37 Billion EUR | -10.45% |
2003 Q1 | 3.78 Billion EUR | 0.52% |
2003 Q3 | 3.73 Billion EUR | -0.33% |
2003 Q4 | 3.37 Billion EUR | -9.75% |
2003 Q2 | 3.74 Billion EUR | -0.97% |
2002 Q3 | 4.02 Billion EUR | -0.18% |
2002 FY | 3.76 Billion EUR | -13.65% |
2002 Q1 | 4.39 Billion EUR | 0.91% |
2002 Q4 | 3.76 Billion EUR | -6.46% |
2002 Q2 | 4.03 Billion EUR | -8.36% |
2001 Q4 | 4.35 Billion EUR | 5.71% |
2001 Q3 | 4.12 Billion EUR | -5.33% |
2001 FY | 4.35 Billion EUR | 24.88% |
2001 Q1 | 4.1 Billion EUR | 17.66% |
2001 Q2 | 4.35 Billion EUR | 6.06% |
2000 Q4 | 3.49 Billion EUR | -7.3% |
2000 Q3 | 3.76 Billion EUR | 0.14% |
2000 Q2 | 3.76 Billion EUR | 7.7% |
2000 Q1 | 3.49 Billion EUR | -5.75% |
2000 FY | 3.49 Billion EUR | -5.77% |
1999 FY | 3.7 Billion EUR | 31.58% |
1999 Q4 | 3.7 Billion EUR | 0.0% |
1998 Q4 | 2.81 Billion EUR | 0.0% |
1998 FY | 2.81 Billion EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
The Amacore Group, Inc. | 24.7 Million USD | -77210.997% |
Arem Pacific Corporation | 304.9 Thousand USD | -6265260.787% |
Assisted 4 Living, Inc. | 184.16 Thousand USD | -10372699.144% |
BioCorRx Inc. | 10.34 Million USD | -184625.982% |
Bionik Laboratories Corp. | 5 Million USD | -381758.111% |
Banyan Corp. | 4.51 Million USD | -422685.261% |
Clearday, Inc. | 65.13 Million USD | -29230.047% |
Dental Patient Care America, Inc. | 1.8 Million USD | -1059955.624% |
Quantum Medical Transport, Inc. | 1504.02 USD | -1270147437.932% |
Empower Clinics Inc. | 9.18 Million USD | -207866.62% |
First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -60251.63% |
Selectis Health, Inc. | 43.63 Million USD | -43679.451% |
Ethema Health Corporation | 17.71 Million USD | -107709.591% |
HealthLynked Corp. | 3.47 Million USD | -549569.622% |
HQDA Elderly Life Network Corp. | - USD | -Infinity% |
Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -131876.522% |
JRSIS Health Care Corporation | 2.3 Million USD | -828611.765% |
Comjoyful International Company | 6.32 Million USD | -301875.753% |
Medical Facilities Corporation | 235.37 Million USD | -8016.219% |
MedSmart Group Inc. | 927.53 Thousand USD | -2059483.238% |
North America Frac Sand, Inc. | 936.85 Thousand USD | -2038996.227% |
Nova Leap Health Corp. | 2.69 Million USD | -707702.313% |
Nexteligent Holdings, Inc. | 2.88 Million USD | -662717.191% |
PAO Group, Inc. | 1.04 Million USD | -1825236.005% |
Primemd Inc. | 7.98 Million USD | -239028.891% |
Raffles Medical Group Ltd | 367.04 Million USD | -5104.577% |
Ryman Healthcare Limited | 5.17 Billion USD | -268.792% |
Stem Cell Authority, Ltd. | 80.52 Thousand USD | -23723306.396% |
SETO Holdings, Inc. | - USD | -Infinity% |
Optima Medical Innovations Corp. | 3.91 Million USD | -487748.723% |
Mycotopia Therapies, Inc. | 4.24 Million USD | -449629.726% |
U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -2825827.959% |
Veltex Corporation | 2.87 Million USD | -663844.832% |
World Financial Holding Group | 132.5 Thousand USD | -14416920.49% |
Xcelerate Inc. | 2.07 Million USD | -920286.833% |